Skip to main content

Advertisement

Log in

The value of 15-minute delayed contrast-enhanced CT to differentiate hyperattenuating adrenal masses compared with chemical shift MR imaging

  • Urogenital
  • Published:
European Radiology Aims and scope Submit manuscript

Abstract

Objectives

To investigate the diagnostic performance of 15-min delayed contrast-enhanced computed tomography (15-DECT) compared with that of chemical shift magnetic resonance (CSMR) imaging in differentiating hyperattenuating adrenal masses and to perform subgroup analysis in underlying malignancy and non-malignancy.

Methods

This study included 478 adrenal masses in 453 patients examined with 15-DECT and 235 masses in 217 patients examined with CSMR. Relative percentage washout (RPW) and absolute percentage washout (APW) on 15-DECT, and signal intensity index (SII) and adrenal-to-spleen ratio (ASR) on CSMR were measured. Sensitivity, specificity and accuracy of 15-DECT and CSMR were analysed for characterisation of adrenal adenoma. Subgroup analyses were performed in patients with and without underlying malignancy. Attenuation and size of the masses on unenhanced CT correlated with the risk of non-adenoma.

Results

RPW calculated from 15-DECT showed the highest diagnostic performance for characterising hyperattenuating adrenal masses regardless of underlying malignancy, and the sensitivity, specificity and accuracy were 91.7 %, 74.8 % and 88.1 %, respectively in all patients. The risk of non-adenoma increased approximately threefold as mass size increased 1 cm or as its attenuation value increased by 10 Hounsfield units.

Conclusions

15-DECT was more accurate than CSMR in characterising hyperattenuating adrenal masses regardless of underlying malignancy.

Key Points

• Delayed contrast-enhanced CT and chemical shift magnetic resonance (CSMR) characterise adrenal lesions.

• 15-min DECT is more accurate than CSMR in characterising hyperattenuating adrenal masses.

• Sensitivity of CSMR decreases as the CT attenuation of adenomas increases.

• Risk of non-adenoma is increased 2.9-fold as size increased by 1 cm.

• Risk of non-adenoma is increased 2.9-fold as attenuation increased by 10 HU.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Song JH, Chaudhry FS, Mayo-Smith WW (2008) The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy. AJR Am J Roentgenol 190:1163–1168

    Article  PubMed  Google Scholar 

  2. Park BK, Kim CK, Kim B, Lee JH (2007) Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses. Radiology 243:760–765

    Article  PubMed  Google Scholar 

  3. Blake MA, Kalra MK, Sweeney AT et al (2006) Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay. Radiology 238:578–585

    Article  PubMed  Google Scholar 

  4. Francis IR, Smid A, Gross MD, Shapiro B, Naylor B, Glazer GM (1988) Adrenal masses in oncologic patients: functional and morphologic evaluation. Radiology 166:353–356

    CAS  PubMed  Google Scholar 

  5. Mayo-Smith WW, Boland GW, Noto RB, Lee MJ (2001) State-of-the-art adrenal imaging. Radiographics 21:995–1012

    Article  CAS  PubMed  Google Scholar 

  6. Young WF Jr (2007) Clinical practice. The incidentally discovered adrenal mass. N Engl J Med 356:601–610

    Article  CAS  PubMed  Google Scholar 

  7. Zeiger MA, Siegelman SS, Hamrahian AH (2011) Medical and surgical evaluation and treatment of adrenal incidentalomas. J Clin Endocrinol Metab 96:2004–2015

    Article  CAS  PubMed  Google Scholar 

  8. Caoili EM, Korobkin M, Francis IR, Cohan RH, Dunnick NR (2000) Delayed enhanced CT of lipid-poor adrenal adenomas. AJR Am J Roentgenol 175:1411–1415

    Article  CAS  PubMed  Google Scholar 

  9. Caoili EM, Korobkin M, Francis IR et al (2002) Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 222:629–633

    Article  PubMed  Google Scholar 

  10. Muth A, Hammarstedt L, Hellstrom M, Sigurjonsdottir HA, Almqvist E, Wangberg B (2011) Cohort study of patients with adrenal lesions discovered incidentally. Br J Surg 98:1383–1391

    Article  CAS  PubMed  Google Scholar 

  11. Merkle EM, Schindera ST (2007) MR imaging of the adrenal glands: 1.5T versus 3T. Magn Reson Imaging Clin N Am 15:365–372

    Article  PubMed  Google Scholar 

  12. Nakamura S, Namimoto T, Morita K et al (2012) Characterization of adrenal lesions using chemical shift MRI: comparison between 1.5 Tesla and two echo time pair selection at 3.0 Tesla MRI. J Magn Reson Imaging 35:95–102

    Article  PubMed  Google Scholar 

  13. Siegelman ES (2012) Adrenal MRI: techniques and clinical applications. J Magn Reson Imaging 36:272–285

    Article  PubMed  Google Scholar 

  14. Blake MA, Cronin CG, Boland GW (2010) Adrenal imaging. AJR Am J Roentgenol 194:1450–1460

    Article  PubMed  Google Scholar 

  15. Low G, Dhliwayo H, Lomas DJ (2012) Adrenal neoplasms. Clin Radiol 67:988–1000

    Article  CAS  PubMed  Google Scholar 

  16. Low G, Sahi K (2012) Clinical and imaging overview of functional adrenal neoplasms. Int J Urol 19:697–708

    Article  PubMed  Google Scholar 

  17. Taffel M, Haji-Momenian S, Nikolaidis P, Miller FH (2012) Adrenal imaging: a comprehensive review. Radiol Clin North Am 50:219–243

    Article  PubMed  Google Scholar 

  18. Choi YA, Kim CK, Park BK, Kim B (2013) Evaluation of adrenal metastases from renal cell carcinoma and hepatocellular carcinoma: use of delayed contrast-enhanced CT. Radiology 266:514–520

    Article  PubMed  Google Scholar 

  19. Park BK, Kim B, Ko K, Jeong SY, Kwon GY (2006) Adrenal masses falsely diagnosed as adenomas on unenhanced and delayed contrast-enhanced computed tomography: pathological correlation. Eur Radiol 16:642–647

    Article  PubMed  Google Scholar 

  20. Park BK, Kim CK, Kwon GY, Kim JH (2007) Re-evaluation of pheochromocytomas on delayed contrast-enhanced CT: washout enhancement and other imaging features. Eur Radiol 17:2804–2809

    Article  PubMed  Google Scholar 

  21. Ramsay JA, Asa SL, van Nostrand AW, Hassaram ST, de Harven EP (1987) Lipid degeneration in pheochromocytomas mimicking adrenal cortical tumors. Am J Surg Pathol 11:480–486

    Article  CAS  PubMed  Google Scholar 

  22. van Erkel AR, van Gils AP, Lequin M, Kruitwagen C, Bloem JL, Falke TH (1994) CT and MR distinction of adenomas and nonadenomas of the adrenal gland. J Comput Assist Tomogr 18:432–438

    Article  PubMed  Google Scholar 

  23. Outwater EK, Siegelman ES, Huang AB, Birnbaum BA (1996) Adrenal masses: correlation between CT attenuation value and chemical shift ratio at MR imaging with in-phase and opposed-phase sequences. Radiology 200:749–752

    CAS  PubMed  Google Scholar 

  24. Haider MA, Ghai S, Jhaveri K, Lockwood G (2004) Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role? Radiology 231:711–716

    Article  PubMed  Google Scholar 

  25. Park BK, Kim CK, Kim B, Choi JY (2007) Comparison of delayed enhanced CT and 18F-FDG PET/CT in the evaluation of adrenal masses in oncology patients. J Comput Assist Tomogr 31:550–556

    Article  PubMed  Google Scholar 

  26. Sangwaiya MJ, Boland GW, Cronin CG, Blake MA, Halpern EF, Hahn PF (2010) Incidental adrenal lesions: accuracy of characterization with contrast-enhanced washout multidetector CT—10-minute delayed imaging protocol revisited in a large patient cohort. Radiology 256:504–510

    Article  PubMed  Google Scholar 

  27. McGahan JP (1988) Adrenal gland: MR imaging. Radiology 166:284–285

    CAS  PubMed  Google Scholar 

  28. Fujiyoshi F, Nakajo M, Fukukura Y, Tsuchimochi S (2003) Characterization of adrenal tumors by chemical shift fast low-angle shot MR imaging: comparison of four methods of quantitative evaluation. AJR Am J Roentgenol 180:1649–1657

    Article  PubMed  Google Scholar 

  29. Pena CS, Boland GW, Hahn PF, Lee MJ, Mueller PR (2000) Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 217:798–802

    Article  CAS  PubMed  Google Scholar 

  30. Candel AG, Gattuso P, Reyes CV, Prinz RA, Castelli MJ (1993) Fine-needle aspiration biopsy of adrenal masses in patients with extraadrenal malignancy. Surgery 114:1132–1136

    CAS  PubMed  Google Scholar 

  31. Pantalone KM, Gopan T, Remer EM et al (2010) Change in adrenal mass size as a predictor of a malignant tumor. Endocr Pract 16:577–587

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hyuck Jae Choi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koo, H.J., Choi, H.J., Kim, H.J. et al. The value of 15-minute delayed contrast-enhanced CT to differentiate hyperattenuating adrenal masses compared with chemical shift MR imaging. Eur Radiol 24, 1410–1420 (2014). https://doi.org/10.1007/s00330-013-3084-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00330-013-3084-7

Keywords

Navigation